???Providers are looking carefully at everything they do ??? especially things that are complex, such as IV therapies that are more expensive, either for the patient or for the provider and the plan,??? says Edmund Pezalla, MD, MPH, national medical director for pharmacy policy and strategy at Aetna. ???Those things are getting their attention, and they???re asking, ???Is this the right patient fo